on 30 May 2014
Aurobindo Pharma will hold a meeting of the Board of Directors of the Company on 30 May 2014 to consider and approve the Audited Financial Results of the Company for the financial year ended 31 March 2014, to consider recommendation of Final Dividend, if any, for the year 2013-14, and to consider the proposal of payment of Second Interim Dividend for the year 2013-14.Powered by Capital Market - Live News
